Modelling the effectiveness of ibrutinib versus rituximab-based chemotherapy regimens in relapsed/refractory mantle cell lymphoma

Authors:

Crtichlow S, Lee D, Latour A, Wildgust M, Goldberg J, Rule S and Wang M.

Publication Type:

Conference Proceedings – Poster

Publication Name:

19th International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress

Citation:

Critchlow S, Lee D, Latour A, Wildgust M, Goldberg J, Rule S and Wang M. Modelling the effectiveness of ibrutinib versus rituximab-based chemotherapy regimens in relapsed/refractory mantle cell lymphoma. 19th International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress. Vienna Austria. 29 October – 2 November. Poster PCN138.

 


Link to publication ⟶

⟵ Back to Search Results